You are here

DNA

Inovio, with path to market opening up, drafts accelerated approval talking points ahead of FDA meeting

Inovio, with path to market opening up, drafts accelerated approval talking points ahead of FDA meeting

Fierce Biotech

Inovio Pharmaceuticals

Flag link:

Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics

Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics

Stat

Flag link:

Cervical cancer could be diagnosed earlier with new DNA biosensor

Cervical cancer could be diagnosed earlier with new DNA biosensor

Biopharma Reporter

cervical cancer

Flag link:

FDA Gives Okay to DNA Test for Common Hereditary Cancers

FDA Gives Okay to DNA Test for Common Hereditary Cancers

OBR Oncology

Common Hereditary Cancers Panel

Flag link:

DeepMind’s New AI Can Predict Genetic Diseases

DeepMind’s New AI Can Predict Genetic Diseases

Wired

artificial intelligence

Flag link:

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M

Fierce Pharma

Moderna Therapeutics

OriCiro Genomics

Flag link:

Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%

Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%

Reuters

Guardant Health

colorectal cancer

Flag link:

Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants

Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants

Biopharma Reporter

COVID-19 variants clinical trials

Flag link:

Bayer-owned AskBio will shift focus toward its doggybone DNA in restructure with Touchlight

Bayer-owned AskBio will shift focus toward its doggybone DNA in restructure with Touchlight

Endpoints

Flag link:

Merck’s Covid Pill Might Pose Risks for Pregnant Women

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times, NY

Flag link:

Could DNA-based COVID-19 vaccine offer variant-busting booster shot?

Could DNA-based COVID-19 vaccine offer variant-busting booster shot?

Biopharma Reporter

COVID-19 variants

Flag link:

Third Rock launches biotech targeting 'notoriously difficult' DNA regulators

Third Rock launches biotech targeting 'notoriously difficult' DNA regulators

BioPharma Dive

transcription factors

Flare Therapeutics

Flag link:

With a new method to synthesize DNA, San Diego's Molecular Assemblies notches $24M Series A

With a new method to synthesize DNA, San Diego's Molecular Assemblies notches $24M Series A

Endpoints

Molecular Assemblies

Flag link:

The two months in 1980 that shaped the future of biotech

The two months in 1980 that shaped the future of biotech

Stat

Flag link:

Here's the Bigger Story About Moderna That You Might Be Missing

Here's the Bigger Story About Moderna That You Might Be Missing

Motley Fool

Moderna Therapeutics

Flag link:

Regeneron joins $100M round for DNAnexus and its cloud-computing DNA software

Regeneron joins $100M round for DNAnexus and its cloud-computing DNA software

Endpoints

Flag link:

Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing

Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing

Endpoints

Stratos Genomics

Flag link:

'A fourth revolution in cancer therapies': ARCH-backed Boundless Bio flashes big check, makes bigger promises in debut

'A fourth revolution in cancer therapies': ARCH-backed Boundless Bio flashes big check, makes bigger promises in debut

Endpoints

Flag link:

The Rise Of Direct To Consumer Precision Health

The Rise Of Direct To Consumer Precision Health

Forbes

precision health

precision medicine

personalized medicine

Flag link:

AstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival

AstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival

Fierce Biotech

pancreatic cancer

University of Michigan

Flag link:

Pages